What is Boston Scientific's total equity?

Boston Scientific (BSX) reported total equity of $25.86B in Q1 2026.

How has Boston Scientific's total equity changed year-over-year?

Boston Scientific's total equity increased by 16.4% year-over-year, from $22.21B to $25.86B.

What is the long-term trend for Boston Scientific's total equity?

Over 5 years (2020 to 2025), Boston Scientific's total equity has grown at a 9.6% compound annual growth rate (CAGR), from $15.33B to $24.23B.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Boston Scientific BSX Total Equity

Total Equity at other companies

AbbottABT

$52.06B+6.7%

TFX

TeleflexTFX

$3.08B-24.7%

Johnson & JohnsonJNJ

$84.97B+8.3%

HaemoneticsHAE

$796.32M-3.0%

CONMEDCNMD

$1.02B+4.1%

Merit Medical SystemsMMSI

$1.63B+13.9%

Other financials

Income statement

See full

Revenue$5.2B+11.6%

Gross profit$3.6B+12.6%

Operating income$1.1B+19.5%

Net income$1.3B+99.3%

EPS (diluted)$0.90+100%

Balance sheet

See full

Cash & equivalents$850.0M+146%

Total debt$659.0M-94.1%

Total assets$44.4B+10.5%

Cash flow

See full

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.3%

Free cash flow$171.0M-51.7%

Valuation

See full

Market cap$65.77B-58.0%

P/E18.5×-44.2×

P/S3.2×-5.3×

Profitability

See full

Gross margin69.2%+0.5pp

Operating margin18.4%+2.2pp

Net margin17.3%+5.7pp

FCF margin16.9%-0.3pp

Returns & leverage

See full

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Boston Scientific's total equity?: Boston Scientific (BSX) reported total equity of $25.86B in Q1 2026.
How has Boston Scientific's total equity changed year-over-year?: Boston Scientific's total equity increased by 16.4% year-over-year, from $22.21B to $25.86B.
What is the long-term trend for Boston Scientific's total equity?: Over 5 years (2020 to 2025), Boston Scientific's total equity has grown at a 9.6% compound annual growth rate (CAGR), from $15.33B to $24.23B.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.